Skip to main content

Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

A novel DNA-binding motif in Prostate Tumor Overexpressed-1 (PTOV1) required for the expression of ALDH1A1 and CCNG2 in cancer cells.

PMID: 30922918
Journal: CANCER LETTERS
Year: 2019
Reference: Cancer Lett. 2019 Jun 28;452:158-167. doi: 10.1016/j.canlet.2019.03.019. Epub 2019 Mar 25.
Impact factor: 6.508
Publication type: Paper in international publication
Authors: Paciucci, Rosanna, Ciudad, Carlos J, Noe, Veronique, Morote, Juan, Maggio, Valentina, Canovas, Veronica, Felix, Alex J, Gomez, Valenti, de Torres, Ines, Semidey, Maria Eugenia et al.
DOI: 10.1016/j.canlet.2019.03.019

A novel DNA-binding motif in Prostate Tumor Overexpressed-1 (PTOV1) required for the expression of ALDH1A1 and CCNG2 in cancer cells.

PMID: 30922918
Journal: CANCER LETTERS
Year: 2019
Reference: Cancer Lett. 2019 Jun 28;452:158-167. doi: 10.1016/j.canlet.2019.03.019. Epub 2019 Mar 25.
Impact factor:
Publication type: Paper in international publication
Authors: Canovas, Veronica; Ciudad, Carlos J; de Torres, Ines; Felix, Alex J; Gomez, Valenti; Maggio, Valentina; Morote, Juan; Noe, Veronique; Paciucci, Rosanna; Semidey, Maria Eugenia et al.
DOI: 10.1016/j.canlet.2019.03.019

A Novel Homozygous AMRH2 Gene Mutation in a Patient with Persistent Mullerian Duct Syndrome.

PMID: 30933950
Journal: Sexual Development
Year: 2019
Reference: Sex Dev. 2019;13(2):87-91. doi: 10.1159/000499324. Epub 2019 Apr 2.
Impact factor: 2.25
Publication type: Paper in international publication
Authors: Fernandez-Cancio, Monica, Viswanath, Naveen, Puzhankara, Ramakrishnan, Valiyaprambil Pavithran, Praveen, Mora-Palma, Cristina, Camats, Nuria, Audi, Laura, Benito-Sanz, Sara et al.
DOI: 10.1159/000499324

A Novel Homozygous AMRH2 Gene Mutation in a Patient with Persistent Mullerian Duct Syndrome.

PMID: 30933950
Journal: Sexual Development
Year: 2019
Reference: Sex Dev. 2019;13(2):87-91. doi: 10.1159/000499324. Epub 2019 Apr 2.
Impact factor:
Publication type: Paper in international publication
Authors: Audi, Laura; Benito-Sanz, Sara; Camats, Nuria; Fernandez-Cancio, Monica; Mora-Palma, Cristina; Puzhankara, Ramakrishnan; Valiyaprambil Pavithran, Praveen; Viswanath, Naveen et al.
DOI: 10.1159/000499324

A Novel Saliva-Based miRNA Signature for Colorectal Cancer Diagnosis.

PMID: 31757017
Journal: Journal of Clinical Medicine
Year: 2019
Reference: J Clin Med. 2019 Nov 20;8(12). pii: jcm8122029. doi: 10.3390/jcm8122029.
Impact factor: 5.688
Publication type: Paper in international publication
Authors: Rapado-Gonzalez, Oscar, Majem, Blanca, Alvarez-Castro, Ana, Diaz-Pena, Roberto, Abalo, Alicia, Suarez-Cabrera, Leticia, Gil-Moreno, Antonio, Santamaria, Anna, Lopez-Lopez, Rafael, Suarez-Cunqueiro, Maria Mercedes et al.
DOI: 10.3390/jcm8122029

A Novel Saliva-Based miRNA Signature for Colorectal Cancer Diagnosis.

PMID: 31757017
Journal: Journal of Clinical Medicine
Year: 2019
Reference: J Clin Med. 2019 Nov 20;8(12). pii: jcm8122029. doi: 10.3390/jcm8122029.
Impact factor:
Publication type: Paper in international publication
Authors: Abalo, Alicia; Alvarez-Castro, Ana; Diaz-Pena, Roberto; Gil-Moreno, Antonio; Lopez-Lopez, Rafael; Majem, Blanca; Muinelo-Romay, Laura; Rapado-Gonzalez, Oscar; Santamaria, Anna; Suarez-Cabrera, Leticia et al.
DOI: 10.3390/jcm8122029

A phase 1/2, open-label, dose-expansion study of liposomal irinotecan (nal-IRI) plus 5-fluorouracil/leucovorin (5-FU/LV) and oxaliplatin (OX) in patients with previously untreated metastatic pancreatic cancer.

PMID: 32085008
Journal: ANNALS OF ONCOLOGY
Year: 2019
Reference: Ann Oncol. 2019 Jul;30 Suppl 4:iv123. doi: 10.1093/annonc/mdz157.004. Epub 2019 Dec 4.
Impact factor: 14.196
Publication type: Letter or abstract
Authors: Wainberg, Z, Boland, P, Lieu, C, Dayyani, F, Macarulla, T, Zhang, B, Belanger, B, Moore, Y, Wang, T, Maxwell, F et al.
DOI: 10.1093/annonc/mdz157.004

A phase 1/2, open-label, dose-expansion study of liposomal irinotecan (nal-IRI) plus 5-fluorouracil/leucovorin (5-FU/LV) and oxaliplatin (OX) in patients with previously untreated metastatic pancreatic cancer.

PMID: 32085008
Journal: ANNALS OF ONCOLOGY
Year: 2019
Reference: Ann Oncol. 2019 Jul;30 Suppl 4:iv123. doi: 10.1093/annonc/mdz157.004. Epub 2019 Dec 4.
Impact factor:
Publication type: Letter or abstract
Authors: Belanger, B; Boland, P; Dayyani, F; Dean, A; Lieu, C; Macarulla, T; Maxwell, F; Moore, Y; Wainberg, Z; Wang, T et al.
DOI: 10.1093/annonc/mdz157.004

A phase 2 randomised study of veliparib plus FOLFIRI+/-bevacizumab versus placebo plus FOLFIRI+/-bevacizumab in metastatic colorectal cancer.

PMID: 30531832
Journal: BRITISH JOURNAL OF CANCER
Year: 2019
Reference: Br J Cancer. 2019 Jan;120(2):183-189. doi: 10.1038/s41416-018-0343-z. Epub 2018 Dec 11.
Impact factor: 5.416
Publication type: Paper in international publication
Authors: Deming, Dustin A, Ramanathan, Ramesh K, Torres, Alison H, Sullivan, Danielle, Luo, Yan, Berlin, Jordan D, Elez Fernandez, Elena, Mangel, Laszlo, Cubillo Gracian, Antonio, Nechaeva, Marina et al.
DOI: 10.1038/s41416-018-0343-z

A phase 2 randomised study of veliparib plus FOLFIRI+/-bevacizumab versus placebo plus FOLFIRI+/-bevacizumab in metastatic colorectal cancer.

PMID: 30531832
Journal: BRITISH JOURNAL OF CANCER
Year: 2019
Reference: Br J Cancer. 2019 Jan;120(2):183-189. doi: 10.1038/s41416-018-0343-z. Epub 2018 Dec 11.
Impact factor:
Publication type: Paper in international publication
Authors: Beck, J Thaddeus; Berlin, Jordan D; Cubillo Gracian, Antonio; Deming, Dustin A; Elez Fernandez, Elena; Garcia-Alfonso, Pilar; Gorbunova, Vera; Hofheinz, Ralf-Dieter; Luo, Yan; Mangel, Laszlo et al.
DOI: 10.1038/s41416-018-0343-z

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients.

PMID: 31363167
Journal: BRITISH JOURNAL OF CANCER
Year: 2019
Reference: Br J Cancer. 2019 Aug;121(5):378-383. doi: 10.1038/s41416-019-0537-z. Epub 2019 Jul 31.
Impact factor: 5.416
Publication type: Paper in international publication
Authors: Safont, Maria Jose, Gallego, Javier, Gravalos, Cristina, Arrivi, Antonio, Carrato, Alfredo, Conde, Veronica, Ortiz, Maria Jose, Lopez, Carlos, Alonso, Beatriz, Ruiz de Mena, Inmaculada et al.
DOI: 10.1038/s41416-019-0537-z

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients.

PMID: 31363167
Journal: BRITISH JOURNAL OF CANCER
Year: 2019
Reference: Br J Cancer. 2019 Aug;121(5):378-383. doi: 10.1038/s41416-019-0537-z. Epub 2019 Jul 31.
Impact factor:
Publication type: Paper in international publication
Authors: Alonso, Beatriz; Aranda, Enrique; Arrivi, Antonio; Bando, Inmaculada; Carrato, Alfredo; Conde, Veronica; Diaz-Rubio, Eduardo; Elez, Elena; Gallego, Javier; Gravalos, Cristina et al.
DOI: 10.1038/s41416-019-0537-z

A Phase I, Multicenter, Dose-Escalation Study of the Oral Selective FGFR inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring FGFR Gene Alterations.

PMID: 30745300
Journal: CLINICAL CANCER RESEARCH
Year: 2019
Reference: Clin Cancer Res. 2019 May 1;25(9):2699-2707. doi: 10.1158/1078-0432.CCR-18-1959. Epub 2019 Feb 11.
Impact factor: 8.911
Publication type: Paper in international publication
Authors: Voss, Martin H, Cleary, James M, Meric-Bernstam, Funda, Tabernero, Josep, Janku, Filip, Gandhi, Leena, Iafrate, A John, Borger, Darrell R, Ishii, Nobuya, Hu, Youyou et al.
DOI: 10.1158/1078-0432.CCR-18-1959

A Phase I, Multicenter, Dose-Escalation Study of the Oral Selective FGFR inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring FGFR Gene Alterations.

PMID: 30745300
Journal: CLINICAL CANCER RESEARCH
Year: 2019
Reference: Clin Cancer Res. 2019 May 1;25(9):2699-2707. doi: 10.1158/1078-0432.CCR-18-1959. Epub 2019 Feb 11.
Impact factor:
Publication type: Paper in international publication
Authors: Baselga, Jose; Borger, Darrell R; Cleary, James M; Flaherty, Keith T; Gandhi, Leena; Heist, Rebecca S; Hierro, Cinta; Hu, Youyou; Iafrate, A John; Ishii, Nobuya et al.
DOI: 10.1158/1078-0432.CCR-18-1959

A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer.

PMID: 31368034
Journal: BREAST CANCER RESEARCH AND TREATMENT
Year: 2019
Reference: Breast Cancer Res Treat. 2019 Nov;178(1):121-133. doi: 10.1007/s10549-019-05360-3. Epub 2019 Jul 31.
Impact factor: 3.471
Publication type: Paper in international publication
Authors: Reyner, Eric, Bond, John, Cui, Na, Wilson, Timothy R, Moore, Heather M, Saura, Cristina, Krop, Ian E, Wei, Michael C, Richey, Stephen, Becerra, Carlos et al.
DOI: 10.1007/s10549-019-05360-3

A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer.

PMID: 31368034
Journal: BREAST CANCER RESEARCH AND TREATMENT
Year: 2019
Reference: Breast Cancer Res Treat. 2019 Nov;178(1):121-133. doi: 10.1007/s10549-019-05360-3. Epub 2019 Jul 31.
Impact factor:
Publication type: Paper in international publication
Authors: Abramson, Vandana G; Bauer, Todd M; Becerra, Carlos; Bedard, Philippe L; Bond, John; Cervantes, Andres; Cui, Na; Krop, Ian E; Moore, Heather M; Oliveira, Mafalda et al.
DOI: 10.1007/s10549-019-05360-3

A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer.

PMID: 31423336
Journal: ESMO Open
Year: 2019
Reference: ESMO Open. 2019 Jul 22;4(4):e000532. doi: 10.1136/esmoopen-2019-000532. eCollection 2019.
Impact factor: 0
Publication type: Paper in international publication
Authors: Cervantes, Andres, Weisser, Martin, Hasmann, Max, Ceppi, Maurizio, James, Ian, Cejalvo, Juan-Miguel, Fleitas Kanonnikoff, Tania, Felip, Enriqueta, Navarro Mendivil, Alejandro, Martinez Garcia, Maria et al.
DOI: 10.1136/esmoopen-2019-000532

A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer.

PMID: 31423336
Journal: ESMO open
Year: 2019
Reference: ESMO Open. 2019 Jul 22;4(4):e000532. doi: 10.1136/esmoopen-2019-000532. eCollection 2019.
Impact factor:
Publication type: Paper in international publication
Authors: Adessi, Celine; Cejalvo, Juan-Miguel; Ceppi, Maurizio; Cervantes, Andres; Felip, Enriqueta; Fleitas Kanonnikoff, Tania; Hasmann, Max; Jacob, Wolfgang; James, Ian; Lassen, Ulrik et al.
DOI: 10.1136/esmoopen-2019-000532

A Phase II Study of Talazoparib After Platinum or Cytotoxic Nonplatinum Regimens in Patients With Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO).

PMID: 30563931
Journal: CLINICAL CANCER RESEARCH
Year: 2019
Reference: Clin Cancer Res. 2019 May 1;25(9):2717-2724. doi: 10.1158/1078-0432.CCR-18-1891. Epub 2018 Dec 18.
Impact factor: 8.911
Publication type: Paper in international publication
Authors: Turner, Nicholas C, Telli, Melinda L, Rugo, Hope S, Mailliez, Audrey, Ettl, Johannes, Grischke, Eva-Maria, Mina, Lida A, Balmana, Judith, Fasching, Peter A, Hurvitz, Sara A et al.
DOI: 10.1158/1078-0432.CCR-18-1891

A Phase II Study of Talazoparib After Platinum or Cytotoxic Nonplatinum Regimens in Patients With Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO).

PMID: 30563931
Journal: CLINICAL CANCER RESEARCH
Year: 2019
Reference: Clin Cancer Res. 2019 May 1;25(9):2717-2724. doi: 10.1158/1078-0432.CCR-18-1891. Epub 2018 Dec 18.
Impact factor:
Publication type: Paper in international publication
Authors: Balmana, Judith; Chappey, Colombe; Ettl, Johannes; Fasching, Peter A; Grischke, Eva-Maria; Hannah, Alison L; Hurvitz, Sara A; Mailliez, Audrey; Mina, Lida A; Robson, Mark E et al.
DOI: 10.1158/1078-0432.CCR-18-1891

A Potential Role for the STXBP5-AS1 Gene in Adult ADHD Symptoms.

PMID: 30659475
Journal: BEHAVIOR GENETICS
Year: 2019
Reference: Behav Genet. 2019 May;49(3):270-285. doi: 10.1007/s10519-018-09947-2. Epub 2019 Jan 18.
Impact factor: 2.313
Publication type: Paper in international publication
Authors: Kiemeney, L A, Arias-Vasquez, A, Groffen, A J, Spijker, S, Ouwens, K G, Klein, M, Vojinovic, D, Galesloot, T E, Bralten, J, Hottenga, J J et al.
DOI: 10.1007/s10519-018-09947-2

A Potential Role for the STXBP5-AS1 Gene in Adult ADHD Symptoms.

PMID: 30659475
Journal: BEHAVIOR GENETICS
Year: 2019
Reference: Behav Genet. 2019 May;49(3):270-285. doi: 10.1007/s10519-018-09947-2. Epub 2019 Jan 18.
Impact factor:
Publication type: Paper in international publication
Authors: Amin, N; Arias-Vasquez, A; Boomsma, D I; Bralten, J; Buitelaar, J K; den Braber, A; Dolan, C V; Draisma, H H M; Fedko, I O; Franke, B et al.
DOI: 10.1007/s10519-018-09947-2

A propensity score-matched analysis of laparoscopic versus open surgery for rectal cancer in a population-based study.

PMID: 30585686
Journal: Colorectal Disease
Year: 2019
Reference: Colorectal Dis. 2019 Apr;21(4):441-450. doi: 10.1111/codi.14545. Epub 2019 Jan 17.
Impact factor: 2.997
Publication type: Paper in international publication
Authors: Borras, Josep M, Manchon-Walsh, Paula, Aliste, Luisa, Biondo, Sebastiano, Espin, Eloy, Pera, Miguel, Targarona, Eduard, Pallares, Natalia, Vernet, Raul R, Espinas, Josep A et al.
DOI: 10.1111/codi.14545

A propensity score-matched analysis of laparoscopic versus open surgery for rectal cancer in a population-based study.

PMID: 30585686
Journal: Colorectal Disease
Year: 2019
Reference: Colorectal Dis. 2019 Apr;21(4):441-450. doi: 10.1111/codi.14545. Epub 2019 Jan 17.
Impact factor:
Publication type: Paper in international publication
Authors: Aliste, Luisa; Biondo, Sebastiano; Borras, Josep M; Espin, Eloy; Espinas, Josep A; Guarga, Alex; Manchon-Walsh, Paula; Pallares, Natalia; Pera, Miguel; Targarona, Eduard et al.
DOI: 10.1111/codi.14545